@Warrigals
If Mesoblast were offered US$50m upfront and 50% royalty for the pediatric aGVHD program... would you say that was a good outcome? Because that is the best case scenario in terms of a partnership for this program, and those figures are on the generous side.
I'll tell you right now, if we went down that path it would be a terrible commercial outcome for shareholders.
We do not want a partnership that will deteriorate shareholder value. We want partnerships that will generate shareholder value.
CHF, RA, CLBP programs that have multi-billion dollar potential, partnering those programs will net Mesoblast US$100m+ in upfront non-dilutive capital and access to a network of marketing/sales team to distribute the product - something Mesoblast cannot replicate. Those are the partnerships we want.
@Warrigals If Mesoblast were offered US$50m upfront and 50%...
-
- There are more pages in this discussion • 158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.52 |
Change
0.025(1.68%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $15.99M | 10.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 38585 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.52 | 36708 | 23 |
View Market Depth
| Last trade - 15.16pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |